glp-1 and gip receptors receptor agonist Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Demonstrated metabolic effects of GIP, – GLP-1/GIP Receptor Agonists and Diabetic

Chen X, Liu P, Zhang W, Li X, Wang C, Han F, et al

2017;26(3):177-81 Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P

Diabetes, HR 2.56, and obesity, HR 1.33, were associated with a higher hazard of COVID-19-related death, aligned with earlier evidence

With years of clinical use, these therapies have demonstrated their reliability and tolerability

1 H NMR (400 MHz, DMSO-d6) = 10.49 (s, 1H), 8.67 (dd, J = 5.2, 1.8 Hz, 1H), 8.00 (td, J = 7.7, 1.9 Hz, 1H), 7.92 7.83 (m, 2H), 7.66 (d, J = 8.1 Hz, 1H), 7.51 (ddd, J = 7.3, 4.8, 1.1 Hz, 1H), 7.06 6.89 (m, 2H)

Its essential to follow your surgeons advice on activity levels and dietary choices during this period